EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India

Sharad Iyengar, Kirti Iyengar, Ankit Anand, Virendra Suhalka, Manju Jain

Contraception: X · 2022 · 4 · 100079

DOI: 10.1016/j.conx.2022.100079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contraception: X, 2022. Verfasst von Sharad Iyengar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Action Research and Training for Health Society, Udaipur, Rajasthan, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: David and Lucile Packard Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The levonorgestrel-releasing intrauterine device (LNG-IUD) is a well-accepted contraceptive across developed countries, yet there is limited experience in use and acceptance amongst women living in low-resource, developing country settings. We studied the feasibility of providing the LNG-IUD through a primary care service, and its acceptability amongst women living in a low-income, rural-tribal community in India. Study design: We conducted an observational study of feasibility and acceptability at four health facilities (three rural, and one urban) in Rajasthan, India. Women seeking contraception were offered the LNG-IUD in addition to existing contraceptive methods. We followed all those who adopted LNG-IUD from August 2015 to September 2019 (n= 1266) till discontinuation or 12 months, whichever was earlier. The primary outcome was continuation rate and acceptability, and the secondary outcome was change in hemoglobin levels, which we measured before insertion and at 12-month follow-up, using Sahli's method.

Results

Most users lived in villages, were illiterate, belonged to marginalized groups, had 2 or more children, and wished to limit births when they adopted the method. The 12-month continuation rate was 87.6%. Amongst all users, 7.4% of women sought removal for side effects and 2% for change in reproductive intention, while another 2% reported spontaneous expulsion. Most continuing users reported hypomenorrhea (54%) or amenorrhea (42%) by 12 months of use. User satisfaction was high at 91.6%, with 92% of women rating their experience as equaling or exceeding expectations. Moderate and severe anemia reduced, and mean hemoglobin levels increased by 0.7 g/dL (p < 0.01).

Conclusion

Primary care clinics can feasibly deliver LNG-IUD, with high acceptability amongst women living in low resource settings. Given the paucity of long-acting reversible contraceptive options and high prevalence of anemia among women in India and similar countries, the method should be piloted through the public health system.

Implications

Long duration of contraceptive action, ability to reduce menstrual bleeding and reduce anemia, reversibility, and easy removal, combine to make LNG-IUD acceptable to women, especially in regions with high prevalence of anemia. This study demonstrates the feasibility and acceptability of introducing LNG-IUD in a low resource, primary care setting.

Schlagwörter

Stichwörter der Autor:innen

AcceptabilityFeasibilityHormonal IUDIndiaLevonorgestrel-releasing intrauterine deviceLong-acting reversible contraception

Autor:innen und Institutionen

  • Action Research and Training for Health Society, Udaipur, Rajasthan, India.
  • Sexual & Reproductive Health Specialist, Udaipur, Rajasthan, India.
  • Population Research Centre, Institute for Social and Economic Change, Bengaluru, India.

Förderung

  • David and Lucile Packard Foundation

Zitieren

APA

Iyengar, S., Iyengar, K., Anand, A., Suhalka, V., & Jain, M. (2022). Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India. Contraception: X, 4, 100079. https://doi.org/10.1016/j.conx.2022.100079

Vancouver

Iyengar S, Iyengar K, Anand A, Suhalka V, Jain M. Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India. Contraception: X. 2022;4:100079. doi:10.1016/j.conx.2022.100079

BibTeX
@article{Iyengar2022,
  author = {Iyengar, Sharad and Iyengar, Kirti and Anand, Ankit and Suhalka, Virendra and Jain, Manju},
  title = {Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India},
  journal = {Contraception: X},
  year = {2022},
  volume = {4},
  pages = {100079},
  doi = {10.1016/j.conx.2022.100079}
}
Kostenlos starten →